×
About 4,090 results

ALLMedicine™ Vitiligo Center

Research & Reviews  1,423 results

Do health insurers have an ethical responsibility to cover treatment of vitiligo?
https://doi.org/10.1111/pde.14689
Pediatric Dermatology; Bercovitch L

Dec 2nd, 2021 - Do health insurers have an ethical responsibility to cover treatment of vitiligo?|2021|Bercovitch L,|

Study to Evaluate Adverse Events and Change in Disease Activity With Oral Tablets of Upadacitinib in Adult Participants With Non-Segmental Vitiligo
https://clinicaltrials.gov/ct2/show/NCT04927975

Dec 2nd, 2021 - Vitiligo is a common chronic autoimmune disease that causes the body's immune system to attack its own pigment producing skin cells. This study is to evaluate how safe and effective upadacitinib is in participants with non-segmental vitiligo. Adve...

Clinical Heterogeneity in Acute Symptomatic Seizures due to Autoimmune Encephalitis Rel...
https://doi.org/10.1159/000519229
Neuroimmunomodulation Fan X, Li X et. al.

Dec 1st, 2021 - This study aimed to explore the diversity and clinical features of acute symptomatic seizures due to autoimmune encephalitis related to anti-glutamate decarboxylase (GAD) 65 antibodies. Clinical data of a series of 6 patients positive for anti-GAD...

Inhibition of Fam114A1 protects melanocytes from apoptosis through higher RACK1 express...
https://doi.org/10.18632/aging.203712
Aging Zhou M, Lin F et. al.

Nov 28th, 2021 - Fam114A1 is a gene closely related to the development of nerve cells, melanocytes, and nerve cells that originate from the neural crest of the embryonic ectoderm. Recent studies showed that Fam114A1 has a role in the occurrence of ankylosing myeli...

A Co-morbid Condition of Warts and Vitiligo Treated with Individualized Homeopathy: An ...
https://doi.org/10.1055/s-0041-1733975
Homeopathy : the Journal of the Faculty of Homeopathy; Prusty AK, Bhandari P

Nov 26th, 2021 - Whilst warts and vitiligo are both common skin diseases, their co-morbidity is rare. Here we present a clinical case of warts with vitiligo to illustrate the utility of individualized homeopathic treatment. The homeopathic medicine Sepia officinal...

see more →

Guidelines  1 results

Guidelines for the management of vitiligo: the European Dermatology Forum consensus.
https://doi.org/10.1111/j.1365-2133.2012.11197.x
The British Journal of Dermatology; Taieb A, Alomar A et. al.

Aug 7th, 2012 - The aetiopathogenic mechanisms of vitiligo are still poorly understood, and this has held back progress in diagnosis and treatment. Up until now, treatment guidelines have existed at national levels, but no common European viewpoint has emerged. T...

see more →

Drugs  5 results see all →

Clinicaltrials.gov  60 results

Study to Evaluate Adverse Events and Change in Disease Activity With Oral Tablets of Upadacitinib in Adult Participants With Non-Segmental Vitiligo
https://clinicaltrials.gov/ct2/show/NCT04927975

Dec 2nd, 2021 - Vitiligo is a common chronic autoimmune disease that causes the body's immune system to attack its own pigment producing skin cells. This study is to evaluate how safe and effective upadacitinib is in participants with non-segmental vitiligo. Adve...

A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy
https://clinicaltrials.gov/ct2/show/NCT03076554

Nov 17th, 2021 - Background Platinum-based chemotherapy is the standard of care for advanced unresectable thymic epithelial tumors (TETs). However more than half of these patients experience disease recurrence and require second-line therapy. There are no approved...

Stress Response Pathways in Vitiligo
https://clinicaltrials.gov/ct2/show/NCT02797574

Nov 16th, 2021 - Identifying a role for NF-κB signaling in vitiligo may improve therapies for this disfiguring disorder. Current treatments vary in effectiveness and may not always be long lasting cases. The NF-κB pathway and IL-6 itself are the target of several ...

A Study to Evaluate the Mechanism of Action of Ruxolitinib Cream in Subjects With Vitiligo (TRuE-V MOA)
https://clinicaltrials.gov/ct2/show/NCT04896385

Nov 11th, 2021 - The purpose of the study is to evaluate the Mechanism Of Action (MOA) of ruxolitinib cream in vitiligo by assessing the change in biomarkers.

Evaluation of AMG 714 for Vitiligo
https://clinicaltrials.gov/ct2/show/NCT04338581

Nov 1st, 2021 - The primary objective of this trial is to determine the efficacy of interleukin-15 (IL-15) inhibition with AMG 714 at inducing facial repigmentation in vitiligo. The secondary objectives are to: -Evaluate the safety and tolerability of AMG 714 in ...

see more →

News  140 results

Ruxolitinib Cream Meets Primary Endpoints in Phase 3 Vitiligo Trial
https://www.medscape.com/viewarticle/960220

Oct 4th, 2021 - A topical cream formulation of the JAK inhibitor ruxolitinib was superior to its vehicle for treating vitiligo across all primary and secondary endpoints in two multicenter phase 3 trials presented together at the annual meeting of the European Ac...

Explaining Away Those Shades of Gray
https://www.mdedge.com/clinicianreviews/article/245899/dermatology/explaining-away-those-shades-gray
Joe R. Monroe, MPAS, PA

Sep 9th, 2021 - ANSWER The correct answer is that new hairs growing in to replace those lost from alopecia areata tend to be white (choice “b”). They usually regain their normal color, eventually.

Insurance Coverage for Vitiligo Treatment Varies Widely in the US, Analysis Finds
https://www.medscape.com/viewarticle/956472

Aug 12th, 2021 - Health insurance coverage policies for vitiligo treatment lack uniformity and are marked by significant gaps in coverage, which may disproportionately affect patients of color. Those are the conclusions from an analysis of vitiligo treatment cover...

Cross-Sectional Study Finds Chronic Skin Conditions Have Highest Opioid Prescribing Rates
https://www.medscape.com/viewarticle/953102

Jun 15th, 2021 - Opioids were prescribed most often for vitiligo, hemangioma, pemphigus, atopic dermatitis, and psoriasis, according to a study that used national ambulatory care data to evaluate pain medication use at dermatology visits. "Overall, opioid prescrib...

Checkpoint Inhibitor Skin Side Effects More Common in Women
https://www.medscape.com/viewarticle/950535

May 5th, 2021 - Women had about a twofold higher risk than men of developing dermatologic adverse events while taking immune checkpoint inhibitors for metastatic melanoma in a review of 235 patients at Dana Farber Cancer Center, Boston, Massachusetts. Overall, 62...

see more →

Patient Education  7 results see all →